Search
News
Important Only
Harmony Biosciences Q1 revenue rises less than expected
OverviewU.S. rare disease drugmaker's Q1 product revenue rose 17% yr/yr but missed analyst expectationsQ1 net income fell yr/yr due to higher R&D and licensing costsCompany reiterated 2026 revenue guidance of $1.0 bln to $1.04 blnOutlookCompany reiterates 2026 net revenue guidance of $1.0 bl...Reuters
Thu, May 7
Gibraltar Q1 adjusted EPS misses estimates, reaffirms guidance
OverviewUS building products maker's Q1 net sales rose 44.6% yr/yr, driven by acquisitionsAdjusted EPS for Q1 fell 50% and missed analyst expectationsCompany reaffirmed 2026 guidance and raised OmniMax synergy target to $26 mlnOutlookGibraltar Industries reaffirms 2026 net sales guidance of $1.7...Reuters
Thu, May 7
WhiteHorse Finance Q1 investment income falls
OverviewU.S. business lender's Q1 total investment income fell 8.5% from prior quarterCompany declared Q1 distribution of $0.25 per share; incentive fee reduced for next quarterOutlookWhiteHorse Advisers to reduce incentive fee rate to 17.5% for next fiscal quarterCompany says it remains focused...Reuters
Thu, May 7
Zura Bio Q1 net loss widens as expenses rise
OverviewU.S. biotech firm's Q1 net loss widened yr/yr as R&D and G&A expenses increasedCompany raised $144 mln in February public offering to support pipeline advancementCash and equivalents rose to $225.6 mln, expected to fund operations through at least 2028OutlookZura expects topline ...Reuters
Thu, May 7
Citigroup targets 11% to 13% near-term return on tangible assets
May 7 (Reuters) - Citigroup C.N is targeting an adjusted return on tangible common equity of 11% to 13% for 2027 and 2028, the bank said ahead of its investor day on Thursday. The new targets compare with Citi's ambition of achieving an ROTCE between 10% and 11% this year. The metric is an impor...Reuters
Thu, May 7
Inspired Entertainment Inc - Q1 Revenue $57.2 Million Core Revenue Up 15% Year-Over-Year - SEC Filing
May 7 (Reuters) - Inspired Entertainment Inc INSE.O:INSPIRED ENTERTAINMENT INC - Q1 REVENUE $57.2 MILLION; CORE REVENUE UP 15% YEAR-OVER-YEAR - SEC FILINGINSPIRED ENTERTAINMENT INC - REITERATES FY2026 ADJUSTED EBITDA TARGET RANGE $112 MILLION-$118 MILLION - SEC FILINGSource text: []Reuters
Thu, May 7
Fmc Corporation Announces Agreement To Divest India Commercial Business To Crystal Crop Protection Limited
May 7 (Reuters) - FMC Corp FMC.N:FMC CORPORATION ANNOUNCES AGREEMENT TO DIVEST INDIA COMMERCIAL BUSINESS TO CRYSTAL CROP PROTECTION LIMITEDFMC CORP - DEAL CONSIDERATION IS $252 MILLION USD SUBJECT TO ADJUSTMENTSFMC CORP - TO ALLOCATE ALL SALE PROCEEDS TO DEBT REDUCTIONFMC CORP - TO RECEIVE ALL CASH ...Reuters
Thu, May 7
CORRECTED-GPGI Q1 adjusted net sales rise 3%
OverviewUS multi-industry platform's Q1 pro forma adjusted net sales rose 3% year-over-yearPro forma adjusted EBITDA for Q1 fell 16% year-over-yearHusky unit impacted by oil and resin price volatility and tariff uncertaintyOutlookGPGI sees Q2 2026 adjusted net sales of $425 mln to $475 mlnCompan...Reuters
Thu, May 7
Plus Therapeutics Receives Medicare Enrollment Approval For Cnside Diagnostic
May 7 (Reuters) - Plus Therapeutics Inc PSTV.O:PLUS THERAPEUTICS RECEIVES MEDICARE ENROLLMENT APPROVAL FOR CNSIDE DIAGNOSTICPLUS THERAPEUTICS INC - CNSIDE DIAGNOSTICS ENABLED TO SUBMIT CLAIMS FOR CNSIDE CSF ASSAY PLATFORMPLUS THERAPEUTICS INC - PAYMENT RATE FOR CPT CODE 0640U EFFECTIVE FOR BILLING J...Reuters
Thu, May 7
Quasaredge Acquisition Corporation Signs Letter Of Intent To Acquire Robseek Intelligence Inc.
May 7 (Reuters) - QuasarEdge Acquisition Corp QRED.N:QUASAREDGE ACQUISITION CORPORATION SIGNS LETTER OF INTENT TO ACQUIRE ROBSEEK INTELLIGENCE INC.QUASAREDGE ACQUISITION CORP - ENTERS NON-BINDING LOI TO BUY ROBSEEK INTELLIGENCEQUASAREDGE ACQUISITION CORP - EXCHANGE RATIO ONE QUASAREDGE SHARE PER ROB...Reuters
Thu, May 7
Canopy Growth And Spectrum Therapeutics Expand Medical Portfolio With New 30 And 90-Pack Softgels And Enhanced Dosing Options
May 7 (Reuters) - Canopy Growth Corp WEED.TO:CANOPY GROWTH AND SPECTRUM THERAPEUTICS EXPAND MEDICAL PORTFOLIO WITH NEW 30 AND 90-PACK SOFTGELS AND ENHANCED DOSING OPTIONSReuters
Thu, May 7
Myers Industries Q1 adjusted EPS jumps 57% yr/yr
OverviewU.S. industrial products maker's Q1 revenue rose 1.8% year-over-yearAdjusted EPS for Q1 grew 57% year-over-yearCompany benefited from lower material costs and transformation initiativesOutlookCompany expects moderate growth in Industrial and strong growth in Infrastructure for 2026Myers ...Reuters
Thu, May 7
Fairfax India To Acquire Additional Equity Interest In Iifl Capital Services Limited
May 7 (Reuters) - Fairfax India Holdings Corp FIHu.TO:FAIRFAX INDIA TO ACQUIRE ADDITIONAL EQUITY INTEREST IN IIFL CAPITAL SERVICES LIMITEDFAIRFAX INDIA HOLDINGS CORP - TO INCREASE IIFL CAPITAL OWNERSHIP TO AT LEAST 51%FAIRFAX INDIA HOLDINGS CORP - TO SUBSCRIBE 10% NEW IIFL CAPITAL SHARES AT INR 350,...Reuters
Thu, May 7
Shift4 Payments Q1 gross profit rises 54%, helped by international expansion
OverviewPayment technology provider's Q1 gross profit rose 54% yr/yr to $370 mlnQ1 net income reached $12 mlnCompany attributed results to resilient operations amid volatility and global travel impactsOutlookShift4 Payments leaves full-year guidance unchanged amid current market volatilityCompan...Reuters
Thu, May 7
Monte Rosa Therapeutics Q1 collaboration revenue drops 95%
OverviewUS biotech firm's Q1 collaboration revenue fell 95% yr/yrCompany posted Q1 net loss after prior-year profitCash position rose after $345 mln equity offering in JanuaryOutlookMonte Rosa expects GFORCE-1 trial readout in subjects with elevated CVD risk in H2 2026Company plans to initiate m...Reuters
Thu, May 7
Middleby Q1 revenue rises 15% and beats estimates
OverviewUS food equipment maker's Q1 revenue rose 15%, beating analyst expectationsAdjusted EBITDA for Q1 beat analyst expectationsCompany repurchased 2.4 mln shares, about 4.9% of equity, in Q1OutlookMiddleby raises FY 2026 guidance; sees revenue at $3.36-3.44 blnResult DriversCOMMERCIAL FOODSE...Reuters
Thu, May 7
Xeris Biopharma Q1 product revenue jumps 43%, beats estimates
OverviewU.S. biopharma firm's Q1 product revenue rose 43% yr/yr, beating analyst expectationsNet income turned positive in Q1 from a loss a year earlierCompany raised lower end of 2026 revenue guidance to $380 mln-$390 mlnOutlookXeris Biopharma raises 2026 revenue guidance to $380 mln-$390 mlnCo...Reuters
Thu, May 7
CORRECTED-Adidas is entitled to refund of $300 mln from US tariffs, CEO says
MUNICH, May 7 (Reuters) - Adidas ADSGn.DE CEO Bjorn Gulden said the company would be entitled to a refund of $300 million (not euros) from U.S. tariffs after the Supreme Court struck down the government's emergency levies."We haven't booked it yet, but there's a very good chance it ...Reuters
Thu, May 7
Canada's Supremex Q1 revenue rises 6.6% adjusted EBITDA up 11.9%
OverviewCanada envelope and packaging maker's Q1 revenue rose 6.6% yr/yrQ1 adjusted EBITDA increased 11.9%, while adjusted EPS declined yr/yrCompany closed Indianapolis envelope facility and acquired iFlex Labels after quarter-endOutlookCompany expects annual cost savings of over $1.5 mln from E...Reuters
Thu, May 7
Featured Tools
Top News
PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today
Samsung’s Largest Strike in History: Can SK Hynix and Micron Sit Back and Reap the Benefits?
US Stocks Hit New Highs as Warsh Takes Office, Nvidia Gains for Seventh Day, Cerebras Surges in Debut
Anthropic in Talks for Massive $30 Billion Funding, Valuation May Join Trillion-Dollar Ranks
Will Nvidia Stock Pop on May 20 Earnings? How to Position Now
Market Movers
Tradingkey
